Tyra Biosciences TYRA Cash Flow Statement (2020-2026)

NASDAQ TYRA
$21.98 +0.53 (+2.47%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Tyra Biosciences Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

Tyra Biosciences reported cash from operations of -$31.08M and free cash flow of -$31.14M for the quarter ended Jun 2026, down 31.2% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-6.64M-9.93M-14.82M-15.08M-12.51M-12.86M-11.88M-13.27M-21.15M-22.83M-18.19M-18.70M-24.02M-25.57M-28.15M-28.10M-29.87M-33.83M-39.30M-45.56M
Depreciation and Depletion
41.00M-89.86M0.06M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M
Share-based Compensation
0.51M1.87M3.97M2.69M1.02M2.91M2.43M2.53M4.38M4.19M2.70M5.83M5.30M6.70M6.42M3.70M4.10M7.63M7.85M5.80M
Gains from Sales and Divestitures
-0.00M-0.00M-0.00M-0.00M-0.00M
Cash from Operations
-5.58M-9.03M-8.93M-17.17M-12.21M-11.98M-9.85M-9.62M-17.14M-13.53M-22.03M-10.26M-17.90M-19.59M-25.46M-23.68M-22.38M-23.62M-32.57M-31.08M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.04M0.05M0.06M0.07M0.08M0.08M0.08M0.09M0.08M0.10M0.12M0.13M0.13M0.14M0.14M0.14M0.13M0.13M0.14M0.14M
Change in Working Capital
Change in Accured Expenses
1.23M0.10M1.56M0.54M0.05M0.21M-2.02M1.67M4.64M5.08M-6.91M1.94M2.01M2.21M-0.36M-0.49M2.07M2.16M1.20M5.32M
Investing Activities
Capital Expenditures
0.26M0.10M0.24M0.25M0.05M0.02M0.04M0.04M0.08M0.60M0.14M0.47M0.05M0.01M0.01M0.03M0.04M0.06M0.09M0.07M
Cash from Investing Activities
-0.24M-0.10M-0.24M-0.25M-0.05M-0.02M-0.04M-0.04M-0.08M-144.44M18.07M-144.99M21.56M6.96M32.03M20.87M-14.81M34.38M-120.24M17.85M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Repayments
Change in Capital Stock
Net Equity Issued and Repurchased
53.11M-1.51M147.85M
Misc.
Cash from Financing Activities
183.44M-1.51M0.24M0.03M0.36M0.00M0.38M0.37M0.47M0.32M200.31M0.37M0.74M0.71M2.19M0.58M0.65M4.68M160.38M2.10M
Change in Cash
177.62M-10.64M-8.93M-17.39M-11.90M-12.00M-9.51M-9.29M-16.76M-157.65M196.36M-154.88M4.40M-11.93M8.76M-2.23M-36.54M15.44M7.57M-11.12M
Free Cash Flow
-5.83M-9.13M-9.16M-17.42M-12.26M-12.00M-9.89M-9.66M-17.23M-14.13M-22.16M-10.73M-17.95M-19.60M-25.47M-23.71M-22.42M-23.68M-32.66M-31.14M
Net Cash Flow
177.62M-10.64M-8.93M-17.39M-11.90M-12.00M-9.51M-9.29M-16.76M-157.65M196.36M-154.88M4.40M-11.93M8.76M-2.23M-36.54M15.44M7.57M-11.12M

Tyra Biosciences Cash Flow Statement API

Pull Tyra Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TYRA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY